INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,101,082 | -29.3% | 129,699 | -8.8% | 0.01% | -25.0% |
| Q2 2023 | $5,797,774 | -5.3% | 142,172 | -13.5% | 0.01% | -11.1% |
| Q1 2023 | $6,123,573 | +63.1% | 164,303 | +52.7% | 0.01% | +50.0% |
| Q4 2022 | $3,754,652 | -20.0% | 107,614 | +28.3% | 0.01% | -25.0% |
| Q3 2022 | $4,693,000 | -2.2% | 83,860 | -8.3% | 0.01% | +14.3% |
| Q2 2022 | $4,797,000 | -25.9% | 91,491 | +1.9% | 0.01% | -22.2% |
| Q1 2022 | $6,478,000 | – | 89,747 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |